It is being billed by doctors as the best drug in weight management, compared to similar drugs available in the market ...

Glucagon-like peptide-1 (GLP-1) and Gastric inhibitory polypeptide (GIP) while Ozempic (Semaglutide) only targets GLP-1.

Obesity affects approximately 100 million Indian adults and is linked to over 200 health complications, including heart ...

Eli Lilly has launched Mounjaro (Tirzepatide) in India, being the first top pharma major to bring out a GLP-1/GIP dual-action weight-loss and diabetes drug into the country.

In India, around 101 million people suffer from diabetes. More than half of these patients do not have their blood sugar ...

Television and film producer, Ektaa Kapoor is not someone to mince her words. She has revealed the real culprit behind poor ...

American pharmaceutical company Eli Lilly has launched its drug, Mounjaro, in India. Mounjaro is administered as a ...

Eli Lilly has launched its diabetes and weight-loss drug Mounjaro in India following approval from the country's drug ...

US giant, Eli Lilly launched Mounjaro (tirzepatide) which is a prescription medicine for adults with type 2 diabetes used ...

The council accorded ‘Acceptance of Necessity’ (AoN) for the procurement of a 1350 HP engine to upgrade the present 1000 HP engine for the T-90 tanks. This will enhance the battlefield mobility of the ...

TV18’s daily newsletter featuring the top 10 stories on markets, corporate updates, economic insights, and financial ...

Pharma giant Eli Lilly has launched a new anti-obesity and diabetes drug in India called Mounjaro. But should you take ...